License submitted to FDA for drug to help those with large B-cell lymphoma
A biologics license application has been submitted to the US Food and Drug Administration (FDA)…
01/07/2022 - 3 minutes
Cancer: Keep up to Date with the Latest in Oncology
As one of the leading causes of death worldwide, cancer receives great focus from the life sciences industry. Indeed, it’s the largest therapeutic focus area for biotech and pharma companies, which are working on a large number of therapeutic approaches, including small molecules, T cell therapies, and antibody therapies.
Global cancer drug sales are estimated to reach €221B by 2024. The top 10 blockbuster drugs are sold by big pharma companies, like Roche, Merck, AbbVie, and Bristol-Myers Squibb. Examples of blockbusters include Keytruda, Rituxan, and Herceptin.
Biotech companies are doing a fair bit of the work as well. Read on to keep up to date with the latest oncology research, discoveries, and market developments.
Show More
Editor's Picks for Cancer
- A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology
- Immuno-Oncology: From Science Fiction to the Mainstream
- ADC Approval Buoys Spirits in Cancer Treatment Space
- Do Natural Killer Cells Hold the Key to Treating Blood Cancers?
- Meet 20 European Immuno-Oncology Companies that are Fighting Cancer
A Guide to Current Therapies in Immuno-Oncology
From a rich history to a growing number of therapies, the immuno-oncology landscape has changed rapidly over the last decade. In this report, we look into its past, discuss present therapeutic approaches, and provide an outlook into its future.
Go to ReportLatest Cancer Articles
Beyond Biotech podcast 3: Ariceum Therapeutics, TWB, Unilever
On this week’s podcast, we have three conversations: with Manfred Rüdiger, CEO of Ariceum Therapeutics;…
01/07/2022 - 9 minutes
Companies unite to bolster diagnostics for cancer and liver disease
Two companies set on making improvements for those with lung cancer, non-alcoholic fatty liver disease…
28/06/2022 - 2 minutes
Breast cancer drug recommended for approval
A cancer drug from AstraZeneca and Daiichi Sankyo called Enhertu, that reduces the risk of…
28/06/2022 - 3 minutes
Trinity, St. James’s and Legend Biotech collaborating on solid tumors
Trinity College and St. James’s Hospital Dublin (SJH) in Ireland have entered into a strategic…
28/06/2022 - 3 minutes
Eye inflammation leads to FDA partial clinical hold on Nuvation Bio solid tumor study
U.S. biopharma company Nuvation Bio Inc. says the Food and Drug Administration (FDA) has placed…
27/06/2022 - 2 minutes
Evaxion Biotech picks candidate for lung cancer trial
A clinical-stage biotech company that specializes in developing AI-driven immunotherapies has chosen its product candidate…
23/06/2022 - 2 minutes
Scancell to produce and clinically validate T cell redirecting bispecific antibodies
Scancell Holdings plc, which develops immunotherapies for the treatment of cancer and infectious disease, has…
23/06/2022 - 3 minutes
Roquefort Therapeutics buys UK biotech in return for shares
Medical biotechnology company, Roquefort Therapeutics, has conditionally agreed to buy UK biotech Oncogeni Ltd in…
22/06/2022 - 2 minutes
New data demonstrates clinical potential of Inivata’s RaDaR technology for breast cancer
Data supporting the detection of minimal residual disease (MRD) has highlighted potential to provide an…
21/06/2022 - 3 minutes
Elypta raises $21M to develop early detection test for all cancers
Elypta, a Swedish diagnostics company aiming to commercialize the first metabolism-based liquid biopsy for early…
21/06/2022 - 2 minutes
Immuneel Therapeutics raises $15M and starts patient trials for CAR-T cancer therapies
Indian biotech start-up Immuneel Therapeutics has announced it has started patient dosing in a CAR-T…
21/06/2022 - 4 minutes
